Studies with rapamycin in various cancer cell lines showed that it increases the number of LC3 puncta suggesting autophagy induction (86, 87), but not apoptosis, and this effect is synergized in combination with PI3K or AKT inhibitors (86). The gene discussed is AKT1; the disease is cancer.